Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Efficacy and Safety of Platinum-Based Chemotherapy for Ovarian Cancer During Pregnancy: A Systematic Review and Meta-Analysis

Efficacy and Safety of Platinum-Based Chemotherapy for Ovarian Cancer During Pregnancy: A... IntroductionBased on the available data on ovarian cancer during pregnancy, we performed a review and meta-analysis to evaluate the efficacy and safety of platinum-based chemotherapy against ovarian cancer during pregnancy.MethodsWe systematically searched three databases including the PubMed, Embase, and Cochrane Library databases for articles published from January 1986 to December 2020 using the following terms: “ovarian tumors OR ovarian carcinoma OR adnexal masses OR ovarian cancer” AND “pregnancy” AND “chemotherapy.” Two authors (Yaping Pei and Yuanfeng Gou) independently searched the literature and extracted data from each eligible study. The outcome measures were overall survival (OS) and progression-free survival (PFS). The OS and PFS of all patients were estimated by Kaplan–Meier survival curves and log-rank tests.ResultsA total of 43 studies including 55 cases of ovarian cancer during pregnancy were selected. Forty-eight patients were comprehensively staged using the International Federation of Gynecology and Obstetrics (FIGO) staging system. Twenty-six of the 48 patients (54.17%) were diagnosed with early-stage disease, while the remaining had advanced stages (II, III, and IV). The mean age at diagnosis was 29.31 years. The majority of patients in this meta-analysis were diagnosed at a mean gestational age of 16.05 weeks. The mean GA at chemotherapy administration was 17.42 weeks. Overall, 55 women gave birth to 56 newborns, including a pair of twins. At the end of follow-up (median 10 months, range 0–73 months), all the children were healthy, except for one child who died 5 days after delivery due to a congenital abnormality. During 2–204 months of follow-up, there were five cases of recurrence, with no evidence of recurrence in the remaining cases. Unfortunately, one patient died 29 months after diagnosis. Neither median overall survival nor median progression-free survival was obtained.ConclusionPlatinum-based chemotherapy may be a good choice for pregnant women with ovarian cancer who want to continue their pregnancy. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Efficacy and Safety of Platinum-Based Chemotherapy for Ovarian Cancer During Pregnancy: A Systematic Review and Meta-Analysis

Download PDF
19 pages

Loading next page...
 
/lp/springer-journals/efficacy-and-safety-of-platinum-based-chemotherapy-for-ovarian-cancer-V0XZOOgAhe
Publisher
Springer Journals
Copyright
Copyright © The Author(s) 2021
ISSN
2366-1070
eISSN
2366-1089
DOI
10.1007/s40487-021-00179-9
Publisher site
See Article on Publisher Site

Abstract

IntroductionBased on the available data on ovarian cancer during pregnancy, we performed a review and meta-analysis to evaluate the efficacy and safety of platinum-based chemotherapy against ovarian cancer during pregnancy.MethodsWe systematically searched three databases including the PubMed, Embase, and Cochrane Library databases for articles published from January 1986 to December 2020 using the following terms: “ovarian tumors OR ovarian carcinoma OR adnexal masses OR ovarian cancer” AND “pregnancy” AND “chemotherapy.” Two authors (Yaping Pei and Yuanfeng Gou) independently searched the literature and extracted data from each eligible study. The outcome measures were overall survival (OS) and progression-free survival (PFS). The OS and PFS of all patients were estimated by Kaplan–Meier survival curves and log-rank tests.ResultsA total of 43 studies including 55 cases of ovarian cancer during pregnancy were selected. Forty-eight patients were comprehensively staged using the International Federation of Gynecology and Obstetrics (FIGO) staging system. Twenty-six of the 48 patients (54.17%) were diagnosed with early-stage disease, while the remaining had advanced stages (II, III, and IV). The mean age at diagnosis was 29.31 years. The majority of patients in this meta-analysis were diagnosed at a mean gestational age of 16.05 weeks. The mean GA at chemotherapy administration was 17.42 weeks. Overall, 55 women gave birth to 56 newborns, including a pair of twins. At the end of follow-up (median 10 months, range 0–73 months), all the children were healthy, except for one child who died 5 days after delivery due to a congenital abnormality. During 2–204 months of follow-up, there were five cases of recurrence, with no evidence of recurrence in the remaining cases. Unfortunately, one patient died 29 months after diagnosis. Neither median overall survival nor median progression-free survival was obtained.ConclusionPlatinum-based chemotherapy may be a good choice for pregnant women with ovarian cancer who want to continue their pregnancy.

Journal

Oncology and Therapy – Springer Journals

Published: Jun 1, 2022

Keywords: Chemotherapy; Meta-analysis; Ovarian cancer; Pregnancy

References

  • Cancer and pregnancy: what should we know about the management with systemic treatment of pregnant women with cancer?
    Pavlidis, N
  • Ovarian cysts and cancer in pregnancy
    Mukhopadhyay, A; Shinde, A; Naik, R
  • Ovarian cancer in pregnancy
    Fruscio, R; de Haan, J; Van Calsteren, K
  • Cancer in pregnancy: fetal and neonatal outcomes
    Backes, CH; Moorehead, PA; Nelin, LD
  • Taxanes in combination with platinum derivatives for the treatment of ovarian cancer during pregnancy: a literature review
    Zheng, X; Zhu, Y; Zhao, Y
  • Endodermal sinus tumor of the ovary associated with pregnancy
    Malone, JM; Gershenson, DM; Creasy, RK
  • Delivery of a normal infant following cisplatin, vinblastine, and bleomycin (PVB) chemotherapy for malignant teratoma of the ovary during pregnancy
    Christman, JE; Teng, NN; Lebovic, GS
  • Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma
    Malfetano, JH; Goldkrand, JW
  • Treatment of advanced epithelial ovarian carcinoma in pregnancy with cisplatin-based chemotherapy
    King, LA; Nevin, PC; Williams, PP
  • Conservative surgical management of dysgerminoma concomitant with pregnancy
    Buller, RE; Darrow, V; Manetta, A
  • Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary
    Henderson, CE; Elia, G; Garfinkel, D
  • Mixed germ cell malignancy of the ovary concurrent with pregnancy
    Horbelt, D; Delmore, J; Meisel, R
  • Detection of platinum-DNA adducts in cord blood lymphocytes following in utero platinum exposure
    Koc, ON; McFee, M; Reed, E
  • An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature
    Elit, L; Bocking, A; Kenyon, C
  • Endodermal sinus tumor in pregnancy
    Malhotra, N; Sood, M
  • Successful treatment of an advanced ovarian serous cystadenocarcinoma in pregnancy with cisplatin, adriamycin and cyclophosphamide (CAP) regimen case report
    Ohara, N; Teramoto, K
  • A case of early-stage epithelial ovarian cancer in pregnancy
    Otton, G; Higgins, S; Phillips, KA
  • Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy
    Sood, AK; Shahin, MS; Sorosky, JI
  • Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer
    Méndez, LE; Mueller, A; Salom, E
  • Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review
    Picone, O; Lhommé, C; Tournaire, M
  • Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review
    Ferrandina, G; Distefano, M; Testa, A
  • Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases
    Han, JY; Nava-Ocampo, AA; Kim, TJ
  • Adnexal masses in pregnancy: surgery compared with observation
    Schmeler, KM; Mayo-Smith, WW; Peipert, JF
  • Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma
    Hubalek, M; Smekal-Schindelwig, C; Zeimet, AG
  • Ovarian cancer during pregnancy: analysis of 15 cases
    Machado, F; Vegas, C; Leon, J
  • Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation: case report and literature review
    Modares Gilani, M; Karimi Zarchi, M; Behtash, N
  • Adjuvant chemotherapy in a pregnant woman with endodermal sinus tumor of the ovary
    Motegi, M; Takakura, S; Takano, H
  • Endodermal sinus tumor diagnosed in pregnancy: a case report
    Robova, H; Rob, L; Hrehorcak, M
  • Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review
    Karimi Zarchi, M; Behtash, N; Modares, GM
  • Ovarian malignant immature teratoma associated with pregnancy–a case report
    Poujade, O; Pujade-Lauraine, E; Levardon, M
  • Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature
    Tabata, T; Nishiura, K; Tanida, K
  • Effects of chemotherapy during pregnancy on the placenta
    Abellar, RG; Pepperell, JR; Greco, D
  • Combined chemotherapy with paclitaxel and carboplatin for mucinous cystadenocarcinoma of the ovary during pregnancy
    Doi, D; Boh, Y; Konishi, H
  • A favorable maternal and neonatal outcome following chemotherapy with etoposide, bleomycin, and cisplatin for management of grade 3 immature teratoma of the ovary
    Ghaemmaghami, F; Abbasi, F; Abadi, AG
  • Cisplatinum and docetaxel for ovarian cancer in pregnancy
    Rouzi, AA; Sahly, NN; Sahly, NF
  • Ruptured ovarian endodermal sinus tumor diagnosed during pregnancy: case report and review of the literature
    Benjapibal, M; Chaopotong, P; Leelaphatanadit, C
  • Ovarian cancer during pregnancy
    Barut, A; Arikan, I; Barut, F
  • Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature
    Serkies, K; Węgrzynowicz, E; Jassem, J
  • Preservation of pregnancy in a patient with acute abdominal pain secondary to advanced and hemorrhagic yolk sac tumor of the right ovary
    Viana, LS; Tsunoda, AT; Nunes, JS
  • Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature
    Cardonick, E; Bhat, A; Gilmandyar, D
  • Ovarian cancer complicated by pregnancy: analysis of 10 cases
    Dobashi, M; Isonishi, S; Morikawa, A
  • Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy
    Ruiz Ramos, J; Roma, E; Palomar, L
  • Intraperitoneal chemotherapy in a pregnant woman with ovarian cancer
    Smith, ER; Borowsky, ME; Jain, VD
  • Management of ovarian cancer in 14th gestational week of pregnancy by robotic approach with preservation of the fetus
    Chen, CH; Chiu, LH; Chan, C
  • Ovarian cancer during pregnancy: a case report and literature review
    Hummeida, ME; Hamad, K; Gadir, AF
  • Management comprehensive multidisciplinary of malignant ovarian germ cell tumors and feto—maternal outcome: a case series report and literature review
    Luh, L; Mahendra, I; Suwiyoga, K
  • Ultrasound features and clinical outcome of patients with malignant ovarian masses diagnosed during pregnancy: experience of a gynecological oncology ultrasound center
    Moro, F; Mascilini, F; Pasciuto, T
  • Long-term multidisciplinary integrative therapy management resulted in favorable outcomes for ovarian cancer during pregnancy: a case report and literature review
    Xu, T; Wang, L; Jia, Y
  • Clinical characteristics and outcome of cancer diagnosed during pregnancy
    Shim, M; Mok, C; Chang, K
  • Ovarian tumors associated with pregnancy: a 20-year experience in a teaching hospital
    Gasim, T; Al Dakhiel, S; Al Ghamdi, A
  • Treatment of acute myeloid leukemia during pregnancy
    Chang, A; Patel, S
  • Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
    Cotteret, C; Pham, Y; Marcais, A
  • Chemotherapy during pregnancy for advanced colon cancer: a case report
    Frydenberg, H; Harsem, N; Ofigsbø, Å
  • Treatment of breast cancer during pregnancy: an observational study
    Loibl, S; Han, S; von Minckwitz, G
  • Gastric cancer during pregnancy: a report on 13 cases and review of the literature with focus on chemotherapy during pregnancy
    Maggen, C; Lok, C; Cardonick, E
  • Neoadjuvant chemotherapy in locally advanced cervical cancer in pregnancy-Review of the literature
    Mandic, A; Maricic, S; Malenkovic, G
  • Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy
    Mir, O; Berrada, N; Domont, J
  • Use of erlotinib throughout pregnancy: a case-report of a patient with metastatic lung adenocarcinoma
    Rivas, G; Llinás, N; Bonilla, C
  • ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
    Colombo, N; Sessa, C; du Bois, A
  • Ovarian cancer statistics, 2018
    Torre, LA; Trabert, B; DeSantis, CE
  • Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches
    Uccello, M; Boussios, S; Samartzis, EP
  • An elevated maternal serum alpha-fetoprotein leading to the diagnosis of an immature teratoma
    Frederiksen, M; Casanova, L; Schink, J
  • Maternal and fetal survival following surgery and chemotherapy of endodermal sinus tumor of the ovary during pregnancy: a case report
    Kim, D; Park, M
  • Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review
    Mantovani, G; Gramignano, G; Mais, V
  • Adjuvant chemotherapy in a pregnant patient with endodermal sinus tumor of the ovary
    Metz, S; Day, T; Pursell, S
  • The diagnosis of immature teratoma by maternal serum alpha-fetoprotein screening
    Montz, F; Horenstein, J; Platt, L